Discovery of antibodies

Mairion B. Llewelyn, Robert E. Hawkins, Stephen J Russell

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Passive immunisation has been used in clinical practice since the end of last century, mainly for prophylaxis. Success of early treatments was marred by anaphylactic reactions and serum sickness because antibodies or antitoxins were not raised in humans. Recombination of gene segments during antibody synthesis means that specific antibodies for numerous antigens can be produced from a limited gene pool. Killer lymphocytes, phagocytes, and complement then bind to the constant region of the antibody facilitating elimination of the pathogen. Development of a method of obtaining large quantities of antibodies against a specific antigen (monoclonal antibodies) offers the possibility of initiating host defence mechanisms against any unwanted antigen, though some problems still remain in preventing the body, from attacking the monoclonal antibody.

Original languageEnglish (US)
Pages (from-to)1269-1272
Number of pages4
JournalBritish Medical Journal
Volume305
Issue number6864
StatePublished - 1992
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Llewelyn, M. B., Hawkins, R. E., & Russell, S. J. (1992). Discovery of antibodies. British Medical Journal, 305(6864), 1269-1272.